Activist investor Elliott takes stake in drug manufacturer Catalent – source

By Maggie Fick LONDON (Reuters) – Activist investor Elliott Investment has taken a stake in contract drugmaker Catalent, a source familiar with the matter told Reuters on Thursday. The Wall Street Journal reported on Wednesday that Elliott had built a significant stake in Catalent, a New Jersey headquartered, NYSE listed company that does outsourced drug…

Read More

Investors see Japanese equities shining brighter on attractive valuations

By Divya Chowdhury, Anisha Sircar and Lisa Pauline Mattackal MUMBAI (Reuters) – Japanese equities continue to look attractive to foreign and local investors, backed by a significant valuation discount to other developed markets, the continuation of loose monetary policy, and progress made by companies on corporate governance. “We think the land of the rising sun…

Read More